Increase of Plasma IL-12/p40 Ratio Induced by the Combined Therapy of DNA Vaccine and Lamivudine Correlates with Sustained Viremia Control in CHB Carriers |
Im, Se-Jin
(Division of Molecular and Life Sciences, Pohang University of Science & Technology)
Yang, Se-Hwan (Research Institute, Genexine Co. Ltd.) Yoon, Seung-Kew (Department of Internal Medicine, College of Medicine, The Catholic University of Korea) Sung, Young-Chul (Division of Molecular and Life Sciences, Pohang University of Science & Technology) |
1 | Lai CL, Chien RN, Leung NW, Chang TT, Guan R, Tai DI, Ng KY, Wu PC, Dent JC, Barber J, Stephenson SL, Gray DF: A one-year trial of lamivudine for chronic hepatits B. Asia Hepatitis Lamivudine Study Group. N Engl J Med 339;61-68, 1998 DOI ScienceOn |
2 | Guidotti LG, McClary H, Loudis JM, Chisari FV: Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice. J Exp Med 191;1247-1252, 2000 DOI ScienceOn |
3 | Barouch DH, Truitt DM, Letvin NL: Expression kinetics of the interleukin-2/immunoglobulin (IL-2/lg) plasmid cytokine adjuvant. Vacine 22;3092-3097, 2004 |
4 | Cavanaugh VJ, Guidotti LG, Chisari FV: Interleukin-12 inhibits hepatitis B virus replication in transgenic mice. J Virol 71;3236-3243, 1997 |
5 | Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV: Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4;25-36, 1996 DOI ScienceOn |
6 | Heise T, Guidotti LG, Chisari FV: Charcterization of nuclear RNases that cleave hepatitis B virus RNA near the La protein binding aite. J Virol 75;6874-6883, 2001 DOI ScienceOn |
7 | Guidotti LG, Ghisari FV: Cytokine-mediated control of viral infections. Virology 273;221-227, 2000 DOI ScienceOn |
8 | Chisari FV, Ferrari C: Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13;29-60, 1995 DOI ScienceOn |
9 | Yang SH, Lee CG, Park SH, Im SJ, Kim YM, Son JM, Wang JS, Yoon SK, Song MK, Ambrozaitis A, Kharchenko N, Yun YD, Kim CM, Kim CY, Lee SH, Kim BM, Kim WB, Sung YC: Correlation of antiviral T-cell reponses with suppression of ciral rebound in chronic hepatits B carriers:a proof-of-concept study. Gene Ther 13;1110-1117, 2006 DOI ScienceOn |
10 | Carreflo V, Zeuzem S, Hopf U, Marellin P, Cooksley WG, Fevery J, Diago M, Reddy R, Peters M, Rittweger K, Rakhit A, Pardo M: A phase study of recombinant human interleukin-12 in patients with chronic hepatitis B. J Hepatol 32;317-324, 2000 DOI ScienceOn |
11 | Rossol S, Marinos G, Carucci P, Singer MV, Williams R, Naoumov NV: Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitits B. J Virol 71;3236-3243, 1997 |
12 | de Jongh FE, Janssen HL, de Man RA, Hop WC, Schalm SW, van Blankenstein M: Survivial and prognostic indicators in hepatitis B suface antigen-positive cirrhosis of the liver. Gastroenterology 103;1630-1635, 1992 DOI PUBMED |
13 | Lok AS, Heathcote EJ, Hoofnagle JH: Management of hepatitis B: 2000-summary of a workshop. Gastroenterology 120;1828-1853, 2001 DOI ScienceOn |